Menu
Back to Journals » Neuropsychiatric Disease and Treatment » Volume 4 » Issue 6
Neuropsychiatric Disease and Treatment
ISSN: 1178-2021
- View all (4185)
- Volume 20, 2024 (79)
- Volume 19, 2023 (249)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Archive: Volume 4, 2008
Erratum: An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatr Dis Treat, 4: 967–976
Colombo GL, Caruggi M, Di Matteo, et al
Neuropsychiatric Disease and Treatment 2008, 4:1283-1283
Published Date: 5 December 2008
Continuous decrease in serum brain-derived neurotrophic factor (BDNF) levels in a neuropsychiatric syndrome of systemic lupus erythematosus patient with organic brain changes
Atsuko Ikenouchi-Sugita, Reiji Yoshimura, Nobuhisa Ueda, Yuki Kodama, Wakako Umene-Nakano, Jun Nakamura
Neuropsychiatric Disease and Treatment 2008, 4:1277-1281
Published Date: 5 December 2008
Mirror movement associated with neural tube defects
Yasir Andrabi, Farideh Nejat, Mostafa El Khashab, Mohammad Reza Ashrafi
Neuropsychiatric Disease and Treatment 2008, 4:1273-1276
Published Date: 5 December 2008
Progression to vascular dementia of patients with mild cognitive impairment: relevance of mild parkinsonian signs
Marco Mauri, Simona Corbetta, Cristina Pianezzola, Elena Ambrosoni, Giulio Riboldazzi, Giorgio Bono
Neuropsychiatric Disease and Treatment 2008, 4:1267-1271
Published Date: 5 December 2008
Methylphenidate modulates activity within cognitive neural networks of patients with post-stroke major depression: A placebo-controlled fMRI study
Rajamannar Ramasubbu, Bradley G Goodyear
Neuropsychiatric Disease and Treatment 2008, 4:1251-1266
Published Date: 5 December 2008
Post-traumatic stress, depression, and anxiety in patients with injury-related chronic pain: A pilot study
Sofia Åhman, Britt-Marie Stålnacke
Neuropsychiatric Disease and Treatment 2008, 4:1245-1249
Published Date: 5 December 2008
Premorbid intelligence of inpatients with different psychiatric diagnoses does not differ
Paolo Stratta, Ilaria Riccardi, Annarita Tomassini, Maria Marronaro, Roberta Pacifico, Alessandro Rossi
Neuropsychiatric Disease and Treatment 2008, 4:1241-1244
Published Date: 5 December 2008
Clinical presentation of anxiety among patients with epilepsy
M López-Gómez, M Espinola, J Ramirez-Bermudez, I E Martinez-Juarez, A L Sosa
Neuropsychiatric Disease and Treatment 2008, 4:1235-1239
Published Date: 5 December 2008
SPEEDY babies: A putative new behavioral syndrome of unbalanced motor-speech development
Marja-Leena Haapanen, Tuomo Aro, Elina Isotalo
Neuropsychiatric Disease and Treatment 2008, 4:1225-1233
Published Date: 5 December 2008
Pregabalin for the management of partial epilepsy
Philippe Ryvlin, Emilio Perucca, Sylvain Rheims
Neuropsychiatric Disease and Treatment 2008, 4:1211-1224
Published Date: 5 December 2008
Mycophenolate mofetil for myasthenia gravis: a clear and present controversy
Chad Heatwole, Emma Ciafaloni
Neuropsychiatric Disease and Treatment 2008, 4:1203-1209
Published Date: 5 December 2008
New treatment options in the management of fibromyalgia: role of pregabalin
Grazyna Zareba
Neuropsychiatric Disease and Treatment 2008, 4:1193-1201
Published Date: 5 December 2008
New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine
Bernhard T Baune
Neuropsychiatric Disease and Treatment 2008, 4:1181-1192
Published Date: 5 December 2008
Duloxetine in the treatment of generalized anxiety disorder
Trevor R Norman, James S Olver
Neuropsychiatric Disease and Treatment 2008, 4:1169-1180
Published Date: 5 December 2008
Prophylaxis of migraine: general principles and patient acceptance
Domenico D’Amico, Stewart J Tepper
Neuropsychiatric Disease and Treatment 2008, 4:1155-1167
Published Date: 5 December 2008
Bipolar disorder and neurophysiologic mechanisms
Simon M McCrea
Neuropsychiatric Disease and Treatment 2008, 4:1129-1153
Published Date: 5 December 2008
Neurosurgical strategies for Gilles de la Tourette’s syndrome
Karim Mukhida, Matthew Bishop, Murray Hong, Ivar Mendez
Neuropsychiatric Disease and Treatment 2008, 4:1111-1128
Published Date: 5 December 2008
Is schizoaffective disorder a distinct categorical diagnosis? A critical review of the literature
Daniel J Abrams, Donald C Rojas, David B Arciniegas
Neuropsychiatric Disease and Treatment 2008, 4:1089-1109
Published Date: 5 December 2008
An integral approach to the etiopathogenesis of human neurodegenerative diseases (HNDDs) and cancer. Possible therapeutic consequences within the frame of the trophic factor withdrawal syndrome (TFWS)
Salvador Harguindey, Gorka Orive, Ramón Cacabelos, Enrique Meléndez Hevia, Ramón Díaz de Otazu, et al
Neuropsychiatric Disease and Treatment 2008, 4:1073-1087
Published Date: 5 December 2008
Treatment options and patient perspectives in the management of fibromyalgia: future trends
Kim Lawson
Neuropsychiatric Disease and Treatment 2008, 4:1059-1071
Published Date: 5 December 2008
Current migraine management – patient acceptability and future approaches
Arnaud Fumal, Jean Schoenen
Neuropsychiatric Disease and Treatment 2008, 4:1043-1057
Published Date: 5 December 2008
An update on the toxicity of Aβ in Alzheimer’s disease
Jürgen Götz, Lars M Ittner, Nicole Schonrock, Roberto Cappai
Neuropsychiatric Disease and Treatment 2008, 4:1033-1042
Published Date: 5 December 2008
Gelastic seizures associated with hypothalamic hamartomas. An update in the clinical presentation, diagnosis and treatment
José F. Tellez-Zenteno, Cesar Serrano-Almeida, Farzad Moien-Afshari
Neuropsychiatric Disease and Treatment 2008, 4:1021-1031
Published Date: 5 December 2008
Treatment of Lennox-Gastaut syndrome: overview and recent findings
Kenou van Rijckevorsel
Neuropsychiatric Disease and Treatment 2008, 4:1001-1019
Published Date: 5 December 2008